No association between prenatal exposure to psychotropics and intelligence at age five

Acta Obstetricia et Gynecologica Scandinavica

Volumn 94, Issue 5, 2015, Pages 501-507

  Eriksen, Hanne Lise Falgreen ^a   Kesmodel, Ulrik Schiøler ^b,c   Pedersen, Lars Henning ^b   Mortensen, Erik Lykke ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antidepressants; anxiolytics; intelligence; intelligence quotient; prenatal exposure; selective serotonin reuptake inhibitors; Wechsler Preschool and Primary Scales of Intelligence Revised

Indexed keywords

ANXIOLYTIC AGENT; SEROTONIN UPTAKE INHIBITOR; PSYCHOTROPIC AGENT;

ADJUSTMENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASSOCIATION; CHILD; CHILD DEVELOPMENT; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE; INTELLIGENCE QUOTIENT; INTELLIGENCE TEST; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; MOTHER; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; SELF REPORT; WECHSLER INTELLIGENCE SCALE; CASE CONTROL STUDY; DENMARK; DEPRESSIVE DISORDER; DRUG EFFECTS; EPIDEMIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE; PRESCHOOL CHILD; PSYCHOLOGY; VERBAL BEHAVIOR;

ADULT; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DENMARK; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; LONGITUDINAL STUDIES; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTROPIC DRUGS; SEROTONIN UPTAKE INHIBITORS; VERBAL BEHAVIOR;

EID: 84927558840     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12611     Document Type: Article

References (30)

1. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T,. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005; 106 (5 Pt 1): 1071-83.
2. Jimenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Andersen NL, Torp-Pedersen C, et al. Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study. PLoS ONE. 2013; 8: e63034.
3. Wisner KL, Sit DK, Hanusa BH, Moses-Kolko EL, Bogen DL, Hunker DF, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009; 166: 557-66.
4. Einarson A, Choi J, Einarson TR, Koren G,. Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can. 2009; 31: 452-6.
5. Pedersen LH, Henriksen TB, Vestergaard M, Olsen J, Bech BH,. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ. 2009; 339: b3569.
6. Viggedal G, Hagberg BS, Laegreid L, Aronsson M,. Mental development in late infancy after prenatal exposure to benzodiazepines-a prospective study. J Child Psychol Psychiatry. 1993; 34: 295-305.
7. Smith MV, Sung A, Shah B, Mayes L, Klein DS, Yonkers KA,. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors. Early Hum Dev. 2013; 89: 81-6.
8. Pedersen LH, Henriksen TB, Olsen J,. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics. 2010; 125: e600-8.
9. Michielsen LA, van der Heijden FM, Janssen PK, Kuijpers HJ,. Effects of maternal psychotropic drug dosage on birth outcomes. Neuropsychiatr Dis Treat. 2014; 10: 13-8.
10. Pedersen LH, Henriksen TB, Bech BH, Licht RW, Kjaer D, Olsen J,. Prenatal antidepressant exposure and behavioral problems in early childhood-a cohort study. Acta Psychiatr Scand. 2013; 127: 126-35.
11. Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, et al. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry. 2012; 169: 1165-74.
12. Gentile S,. Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anxiety. 2010; 27: 675-86.
13. Velasquez JC, Goeden N, Bonnin A,. Placental serotonin: implications for the developmental effects of SSRIs and maternal depression. Front Cell Neurosci. 2013; 7: 47.
14. Chattopadhyaya B, Di Cristo G,. GABAergic circuit dysfunctions in neurodevelopmental disorders. Front Psychiatry. 2012; 3: 51.
15. Oberlander TF,. Fetal serotonin signaling: setting pathways for early childhood development and behavior. J Adolesc Health. 2012; 51 (2 Suppl.): S9-16.
16. Blakeley PM, Capron LE, Jensen AB, O'Donnell KJ, Glover V,. Maternal prenatal symptoms of depression and down regulation of placental monoamine oxidase A expression. J Psychosom Res. 2013; 75: 341-5.
17. Parfitt Y, Pike A, Ayers S,. The impact of parents' mental health on parent-baby interaction: a prospective study. Infant Behav Dev. 2013; 36: 599-608.
18. Kesmodel US, Underbjerg M, Kilburn TR, Bakketeig L, Mortensen EL, Landrø NI, et al. Lifestyle during pregnancy: neurodevelopmental effects at 5 years of age. The design and implementation of a prospective follow-up study. Scand J Public Health. 2010; 38: 208-19.
19. Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM, et al. The Danish National Birth Cohort-its background, structure and aim. Scand J Public Health. 2001; 29: 300-7.
20. CCFDSM WHO. The anatomical therapeutic chemical classification system with defined daily doses. Geneva, Switzerland: World Health Organization, 2003.
21. Wechsler D,. Manual for the Wechsler Preschool and Primary Scale of Intelligence-Revised. Danish version. Copenhagen: Dansk Psykologisk Forlag, 2006.
22. Wechsler D,. Manual for the Wechsler Adult Intelligence Scale. New York, NY: The Psychological Corporation, 1955.
23. Raven JC,. Standard progressive matrices. Oxford: Oxford Psychologists Press, 1958.
24. Royston P,. Multiple imputation of missing values: further update of ice, with an emphasis on categorical variables. Stata J. 2009; 9: 466-77.
25. Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry. 2002; 159: 1889-95.
26. Mattson SN, Eastvold AD, Jones KL, Harris JA, Chambers CD,. Neurobehavioral follow-up of children prenatally exposed to fluoxetine [abstract]. Teratology. 1999; 59: 376.
27. Roze E, Meijer L, Van Braeckel KNJA, Ruiter SAJ, Bruggink JLM, Bos AF,. Developmental trajectories from birth to school age in healthy term-born children. Pediatrics. 2010; 126: e1134-42.
28. Byatt N, Deligiannidis KM, Freeman MP,. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand. 2013; 127: 94-114.
29. Kesmodel US, Bertrand J, Støvring H, Skarpness B, Denny CH, Mortensen EL, et al. The effect of different alcohol drinking patterns in early to mid-pregnancy on child's intelligence, attention and executive function. BJOG. 2012; 119: 1180-90.
30. Eriksen HL, Kesmodel US, Underbjerg M, Kilburn TR, Bertrand J, Mortensen EL,. Predictors of intelligence at the age of 5: family, pregnancy and birth characteristics, postnatal influences, and postnatal growth. PLoS ONE. 2013; 8: e79200.